Clinical Trials · NCT07573163
Tirzepatide Following Adrenalectomy in Mild Autonomous Cortisol Secretion
- Phase
- Phase 2
- Recruitment status
- Not Yet Recruiting
- Sponsor
- Alaa Sada
- Enrollment
- 34
- Start date
- Jul 2026
- Locations
- 1 site, United States
- Primary endpoint
- Change in systolic blood pressure